The FDA has issued a public health advisory to inform healthcare professionals and patients about a potential cancer risk from use of Elidel (pimecrolimus). This concern is based on information from animal studies, case reports in a small number of patients, and knowledge of how drugs in this class work. It may take human studies of ten years or longer to determine if use of Elidel is linked to cancer. In the meantime, this risk is uncertain, and FDA advises Elidel should be used only for patients after other prescription treatments have failed to work or cannot be tolerated.
What is Elidel?
Elidel is a cream used to treat mild to moderate atopic dermatitis, a form of eczema. It should be used only for a short time. It is not for continuous long-term use.
Elidel should not be the first prescription treatment that you try to treat your atopic dermatitis. Use Elidel only after other prescription treatments did not work or you had too many side effects with other drugs.
Elidel is approved for adults and children 2 years and older with normal immune systems (not weakened or compromised).
Posted by lifedoneright 